文献速递乳腺乳腺X线US

对比增强乳腺X线摄影与低能成像联合或不联合全乳超声在乳腺癌检出中的比较

Comparison of Contrast-enhanced Mammography and Low-Energy Imaging with or without Supplemental Whole-Breast US in Breast Cancer Detection.
PubMed 文献 · Radiology · 2025-01-01

前瞻性研究纳入468名筛查女性,比较CEM、低能图像及低能图像联合全乳超声的乳腺癌检出性能。CEM检出8例癌症(检出率17.1/1000),高于低能联合超声的4例(8.5/1000)和低能单独(2.1/1000),异常解读率亦随检查方法递增。

要点

  • CEM筛查乳腺癌检出率17.1/1000,优于低能联合超声的8.5/1000和低能单独的2.1/1000。
  • 异常解读率低能10.3%、低能联合超声13.7%、CEM18.6%,随附加检查递增。
  • 活检推荐率低能15.0/1000、低能联合超声38.4/1000、CEM42.7/1000,PPV3分别为14.3%、27.8%、45.0%。

核心结论

  • CEM较单独低能成像或低能成像联合全乳超声提高了乳腺癌检出。

研究设计与样本

  • 前瞻性研究,2014年12月至2019年2月招募计划行筛查乳腺X线摄影和全乳超声的女性参与者468名(中位年龄54岁,IQR 48-59岁,均为女性)。

关键影像表现/征象

  • CEM包括低能图像和重组图像,低能图像视觉上等同于全视野数字乳腺X线摄影。
  • 重组图像显示病灶血管性,类似MRI。
  • CEM、低能图像及全乳超声图像由不同的乳腺放射科医师独立解读,彼此不知晓其他模态的发现。

诊断标准与关键数值

  • 筛查检出癌症9个(8名参与者):低能单独检出1个(检出率2.1/1000),低能联合全乳超声检出4个(检出率8.5/1000),CEM检出8个(检出率17.1/1000;P < .05)。
  • 异常解读率:低能10.3%(48/468)、低能联合全乳超声13.7%(64/468)、CEM18.6%(87/468)(P < .001)。
  • 活检推荐率:低能15.0/1000、低能联合全乳超声38.4/1000、CEM42.7/1000。
  • 活检执行PPV3:低能1/7(14.3%)、低能联合全乳超声5/18(27.8%)、CEM9/20(45.0%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Contrast-enhanced mammography (CEM) is an emerging modality that generates low-energy (LE) images that are visually equivalent to full-field digital mammography (FFDM) and recombined images that show lesion vascularity such as MRI. Supplemental whole-breast US increases cancer detection rates when performed with FFDM but not with MRI. Purpose To compare the performance of CEM, LE images, and LE images supplemented with whole-breast US in breast cancer detection during screening. Materials and Methods This prospective study recruited female participants from December 2014 to February 2019 who were scheduled for screening mammography and whole-breast US. CEM (including LE images and recombined images) and whole-breast US images were interpreted by separate breast radiologists blinded to the findings on images from the other modality. Statistical differences in sensitivity and specificity, positive predictive value (PPV), negative predictive value, and abnormal interpretation rate were assessed. Biopsy recommendation rate and PPVs of biopsies performed (PPV3) were calculated at the lesion level. Results Across 468 participants (median age, 54 years [IQR, 48-59 years]; all female participants), nine screen-detected cancers were diagnosed in eight participants: one cancer was depicted at LE imaging alone (cancer detection rate, 2.1 of 1000), four were depicted at LE imaging with whole-breast US (cancer detection rate, 8.5 of 1000), and eight were depicted at CEM (cancer detection rate, 17.1 of 1000; P < .05). The abnormal interpretation rate was 10.3% (48 of 468) for LE images, 13.7% (64 of 468) for LE images with whole-breast US, and 18.6% (87 of 468) for CEM (P < .001). The biopsy recommendation rate was 15.0 of 1000 for LE images, 38.4 of 1000 for LE images with whole-breast US, and 42.7 of 1000 for CEM. Seven biopsies were recommended based on LE images (PPV3 of one of seven [14.3%]), 18 biopsies based on LE images with whole-breast US (with a PPV3 of five of 18 [27.8%]), and 20 biopsies based on CEM (PPV3 of 9 of 20 [45.0%]). Conclusion Breast cancer detection improved with CEM compared with LE images alone or LE images with whole-breast US. ClinicalTrials.gov Identifier: NCT02310698 © RSNA, 2025 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Horvat JV, Amir T, Watt GP, et al. Comparison of Contrast-enhanced Mammography and Low-Energy Imaging with or without Supplemental Whole-Breast US in Breast Cancer Detection. Radiology. 2025. PMID: 40067106. doi:10.1148/radiol.242006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。